Invention Grant
- Patent Title: Cell cycle arrest and apoptosis
- Patent Title (中): 细胞周期停滞和凋亡
-
Application No.: US11665416Application Date: 2004-10-21
-
Publication No.: US07973018B2Publication Date: 2011-07-05
- Inventor: Vicente Planelles , Joshua L. Andersen , Erik Zimmerman
- Applicant: Vicente Planelles , Joshua L. Andersen , Erik Zimmerman
- Applicant Address: US UT Salt Lake City
- Assignee: University of Utah Research Foundation
- Current Assignee: University of Utah Research Foundation
- Current Assignee Address: US UT Salt Lake City
- Agency: Ballard Spahr LLP
- International Application: PCT/US2004/035464 WO 20041021
- International Announcement: WO2006/046951 WO 20060504
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K35/00

Abstract:
The HIV-1 accessory gene vpr encodes a conserved 96-amino acid protein that is necessary and sufficient for the HIV-1-induced block of cellular proliferation and induction of apoptosis. Expression of vpr in CD4+ lymphocytes results in G2 arrest, followed by apoptosis. ATR, as a cellular factor that mediates Vpr-induced cell cycle arrest, is required for activation of the Breast Cancer-Associated Protein-1 (BRCA1). In addition, the Growth Arrest and DNA Damage protein (GADD45) is upregulated by Vpr in an ATR-dependent manner. Posttranscriptional silencing of either ATR or GADD45 leads to nearly complete suppression of the pro-apoptotic and/or cell cycle arrest effect of Vpr.
Public/Granted literature
- US20080300201A1 Cell Cycle Arrest and Apoptosis Public/Granted day:2008-12-04
Information query